Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Strategic Alliance Partners

Latest from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


Systemic Treatment Options Expand in Nonmetastatic NSCLC

February 05, 2021

Although advances in diagnosis and treatment have led to improvements in overall survival for patients with NSCLC, low rates of survival outcomes are present even in those with nonmetastatic disease.

Talking KRAS-Targeted Therapy in NSCLC With Dr. Levy

August 20, 2020

In our exclusive interview, Dr. Levy discusses the challenges of targeting KRAS and highlighted some of the investigational agents directed toward KRAS G12C mutations that have emerged in the NSCLC pipeline.

x